Ingevity Corp

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

NGVT$60.78-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Earnings (Loss) per Share

Index

Note 20: Earnings (Loss) per Share

	Years Ended December 31,
In millions (except share and per share data)	2023	2022	2021
Net income (loss)	$(5.4)	$211.6	$118.1
Basic and Diluted earnings (loss) per share (1)
Basic earnings (loss) per share	$(0.15)	$5.54	$2.97
Diluted earnings (loss) per share	$(0.15)	$5.50	$2.95
Shares (2)
Weighted average number of shares of common stock outstanding - Basic	36,496	38,179	39,816
Weighted average additional shares assuming conversion of potential common shares (3)	—	292	243
Shares - diluted basis	36,496	38,471	40,059

(1) Diluted earnings (loss) per share is calculated using net income (loss) available to common stockholders divided by diluted weighted average shares of common shares outstanding during each period, which includes the dilutive effect of outstanding equity awards.

(2) Shares are presented in thousands.

(3) For the year ended December 31, 2023, all potentially dilutive common shares were excluded from the calculation of diluted earnings (loss) per share as we had a net loss for the period.

The following average number of potential common shares were antidilutive and, therefore, were not included in the diluted earnings per share calculation:

	Years Ended December 31,
In thousands	2023	2022	2021
Average number of potential common shares - antidilutive	571	204	98

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.